Analyst Reco. Amedisys, Inc.

Equities

AMED

US0234361089

Real-time Estimate Cboe BZX Other stock markets 19:16:59 08/05/2024 BST			5-day change	1st Jan Change
94.37 ^USD	+2.18%		+2.96%	-0.47%

04-24	Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03	MT
04-24	Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating	03-25	MT
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating	14/09/23	MT
Deutsche Bank Adjusts Amedisys Price Target to $101 From $97, Maintains Buy Rating	31/07/23	MT
Jefferies Downgrades Amedisys to Hold From Buy, Adjusts Price Target to $101 From $98	06/07/23	MT
Benchmark Downgrades Amedisys to Hold From Buy	27/06/23	MT
Truist Securities Raises Amedisys Price Target to $101 From $97, Maintains Hold Rating	27/06/23	MT
Truist Securities Downgrades Amedisys to Hold From Buy, Price Target is $97	07/06/23	MT
Cantor Fitzgerald Adjusts Price Target on Amedisys to $100 From $91, Keeps Neutral Rating	06/06/23	MT
Credit Suisse Downgrades Amedisys to Neutral From Outperform Due to Competing Offers From Optum, Option Care; Trims PT to $100 From $115	06/06/23	MT
TD Cowen Adjusts Price Target on Amedisys to $84 From $95, Maintains Market Perform Rating	08/05/23	MT
Barclays Adjusts Price Target on Amedisys to $88 From $93, Maintains Equalweight Rating	05/05/23	MT
Truist Securities Adjusts Price Target on Amedisys to $97 From $115, Maintains Buy Rating	04/05/23	MT
UBS Adjusts Amedisys Price Target to $73 From $72, Maintains Sell Rating	04/05/23	MT
Stocks Slip Pre-Bell Following Latest Fed Rate Hike; Asia Mixed, Europe Down	04/05/23	MT
Cantor Fitzgerald Initiates Amedisys at Neutral With $87 Price Target	21/04/23	MT
UBS Adjusts Amedisys Price Target to $72 From $88, Maintains Sell Rating	17/04/23	MT
Truist Securities Adjusts Price Target on Amedisys to $115 From $130, Maintains Buy Rating	13/04/23	MT
Barclays Starts Amedisys at Equalweight With $93 Price Target	13/03/23	MT
RBC Adjusts Price Target on Amedisys to $111 From $114, Maintains Outperform Rating	21/02/23	MT
Benchmark Cuts Amedisys' Price Target to $115 From $120, Maintains Buy Rating	16/02/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Amedisys, Inc.

Equities

AMED

US0234361089

Analyst Reco.

Filters